According to a ranking by Statista and Newsweek, the world's best hospital is the *********** in Rochester, Minnesota. A total of **** U.S. hospitals made it to the top ten list, while one hospital in each of the following countries was also ranked among the top ten best hospitals in the world: Canada, Sweden, Germany, Israel, Singapore, and Switzerland.

According to a ranking by Statista and Newsweek, the best hospital in the United States is the *********** in Rochester, Minnesota. Moreover, the *********** was also ranked as the best hospital in the world, among over 50,000 hospitals in 30 countries. **************** in Ohio and the ************* Hospital in Maryland were ranked as second and third best respectively in the U.S., while they were second and forth best respectively in the World.

The average for 2020 based on 36 countries was 4.44 hospital beds. The highest value was in South Korea: 12.65 hospital beds and the lowest value was in Mexico: 0.99 hospital beds. The indicator is available from 1960 to 2021. Below is a chart for all countries where data are available.

In 2023, Singapore dominated the ranking of the world's health and health systems, followed by Japan and South Korea. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The health and health system index score of the top ten countries with the best healthcare system in the world ranged between 82 and 86.9, measured on a scale of zero to 100.

Global Health Security Index  Numerous health and health system indexes have been developed to assess various attributes and aspects of a nation's healthcare system. One such measure is the Global Health Security (GHS) index. This index evaluates the ability of 195 nations to identify, assess, and mitigate biological hazards in addition to political and socioeconomic concerns, the quality of their healthcare systems, and their compliance with international finance and standards. In 2021, the United States was ranked at the top of the GHS index, but due to multiple reasons, the U.S. government failed to effectively manage the COVID-19 pandemic. The GHS Index evaluates capability and identifies preparation gaps; nevertheless, it cannot predict a nation's resource allocation in case of a public health emergency.

Universal Health Coverage Index  Another health index that is used globally by the members of the United Nations (UN) is the universal health care (UHC) service coverage index. The UHC index monitors the country's progress related to the sustainable developmental goal (SDG) number three. The UHC service coverage index tracks 14 indicators related to reproductive, maternal, newborn, and child health, infectious diseases, non-communicable diseases, service capacity, and access to care. The main target of universal health coverage is to ensure that no one is denied access to essential medical services due to financial hardships. In 2021, the UHC index scores ranged from as low as 21 to a high score of 91 across 194 countries. 

According to a ranking by Statista and Newsweek, the best hospital in Norway is Oslo Universitetssykehus in Oslo. Moreover, Oslo Universitetssykehus was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. St. Olavs Hospital in Trondheim and Haukeland Universitetssykehus in Bergen were ranked as second and third best respectively in the Norway, while they were ***** and ***** best respectively in the World.

The average for 2020 based on 36 countries was 356986 hospital beds. The highest value was in China: 7131200 hospital beds and the lowest value was in Iceland: 1039 hospital beds. The indicator is available from 1960 to 2021. Below is a chart for all countries where data are available.

As of 2022, the largest hospital in the world was found in Henan, China. With seven thousand beds, First Affiliated Hospital of Zhengzhou University was ranked as the largest hospital globally according to its number of beds. The second-largest hospital was also found in China. No U.S. hospital made the world top 20 list, although AdventHealth Orlando was close, being the largest hospital in the United States.

According to a ranking by Statista and Newsweek, the best hospital in Sweden is the Karolinska Universitetssjukhuset in Stockholm. Moreover, Karolinska Universitetssjukhuset was also ranked as the seventh-best hospital in the world, among over ****** hospitals in ** countries. Sahlgrenska Universitetssjukhuset in Göteborg and Akademiska Sjukhuset in Uppsala were ranked as second and third best respectively in the Sweden, while they were **** and **** best respectively in the World.

The average for 2019 based on 26 countries was 1.41 nurse to bed ratio. The highest value was in the United Kingdom: 3.09 nurse to bed ratio and the lowest value was in South Korea: 0.42 nurse to bed ratio. The indicator is available from 1980 to 2020. Below is a chart for all countries where data are available.

According to a ranking by Statista and Newsweek, the best hospital in Denmark is the Rigshospitalet - København in Copenhagen. Moreover, the Rigshospitalet - København was also ranked as the **** best hospital in the world, among over ****** hospitals in ** countries. Aarhus Universitetshospital in Aarhus and Odense Universitetshospital in Odense were ranked as second and third best respectively in the Denmark, while they were **** and **** best respectively in the World.

From the selected regions, the ranking by number of hospitals is led by China with 37,627 hospitals and is followed by the Nigeria (23,640 hospitals). In contrast, the ranking is trailed by Seychelles with one hospitals, recording a difference of 37,626 hospitals to China. Depicted is the number of hospitals in the country or region at hand. As the OECD states, the rules according to which an institution can be registered as a hospital vary across countries.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to 150 countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).

Introduction

The Global Smart Ward Market is poised for significant growth, projected to expand from US$ 3.1 billion in 2023 to an estimated US$ 10.7 billion by 2033, at a compound annual growth rate (CAGR) of 13.2%. North America is at the forefront, holding a dominant 39.8% market share, with US$ 1.2 billion in revenue as of 2023. The region's leadership in this market is underscored by the presence of 87 U.S. and 15 Canadian hospitals ranked among the top 300 smart hospitals globally, according to a Newsweek report. This leadership is primarily fueled by extensive investments in digital health technologies and an increasing focus on enhancing patient care efficiency.

In terms of technological innovation, the Smart Ward sector is driven by the integration of advanced digital infrastructures like the Internet of Things (IoT) and Artificial Intelligence (AI). These technologies are crucial in optimizing hospital operations, improving patient monitoring, and enhancing overall healthcare delivery. The trend towards digitalization is not only improving workflow efficiencies but also supports predictive maintenance of medical equipment, which is vital in managing the rising aging population and the growing prevalence of chronic diseases.

The growth of smart wards also relies on robust policy frameworks that address data privacy, cybersecurity, and ethical technology use. Ensuring that these technological advancements are governed by comprehensive policies will facilitate their safe integration into healthcare settings, thus protecting both patients and healthcare providers. Furthermore, continuous training and capacity building for healthcare professionals are emphasized to equip them with the necessary skills to adapt to these new technologies and protocols effectively.

Public-Private Partnerships (PPPs) play a pivotal role in accelerating the adoption of smart healthcare solutions. By combining resources, expertise, and funding, these partnerships enhance the scalability of smart wards across various regions. Additionally, smart wards are integral to broader smart city initiatives that prioritize sustainable and inclusive urban development. Ensuring accessibility of smart healthcare solutions across different population segments enhances public health outcomes and supports sustainable development.

Looking ahead, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing healthcare investments and rapid adoption of AI and IoT technologies in countries like India, China, and Japan. The Indian Council of Medical Research (ICMR) has recently published ethical guidelines for AI in healthcare, which is anticipated to boost the integration of AI technologies in healthcare facilities, promoting enhanced patient care and operational efficiency in the region. This surge in technological adoption underscores the dynamic expansion of the Smart Ward Market in Asia Pacific, setting the stage for a transformative impact on the global healthcare landscape.

Net-Receivables Time Series for McKesson Corporation. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Ebitda Time Series for McKesson Corporation. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Minority-Interest-Expense Time Series for McKesson Corporation. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

The number of hospital beds ranking is led by China with 6.8 million beds, while Japan is following with 1.5 million beds. In contrast, Seychelles is at the bottom of the ranking with 0.09 thousand beds, showing a difference of 6.8 million beds to China. Depicted is the estimated total number of hospital beds in the country or region at hand.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to 150 countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).

Share-of-Periods-With-Dividend-Payments-In-Percent Time Series for McKesson Corporation. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

In 2024, Bumrungrad International Hospital ranked first among the leading hospitals in Thailand with a score of ** percent. In the same year, it was the only hospital from Thailand that placed 130th among the *** world's best hospitals on the Global Hospital Rating by Newsweek and Statista. Thailand is one of the most popular medical tourism hubs in Southeast Asia.

Research-and-Development Time Series for McKesson Corporation. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Property-Plant-and-Equipment-Net Time Series for McKesson Corporation. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.